TY - JOUR
T1 - Multivalvular disease
T2 - Percutaneous management in 2019 and beyond
AU - Erlebach, Magdalena
AU - Lange, Rüdiger
N1 - Publisher Copyright:
© 2019 Wageningen Academic Publishers. All rights reserved.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
AB - Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
KW - Intervention
KW - Multivalvular disease
KW - Transcatheter aortic valve implantation
KW - Transcatheter mitral valve repair
UR - http://www.scopus.com/inward/record.url?scp=85083401844&partnerID=8YFLogxK
U2 - 10.15420/icr.2019.13.r1
DO - 10.15420/icr.2019.13.r1
M3 - Review article
AN - SCOPUS:85083401844
SN - 1756-1477
VL - 14
SP - 142
EP - 146
JO - Interventional Cardiology: Reviews, Research, Resources
JF - Interventional Cardiology: Reviews, Research, Resources
IS - 3
ER -